Treating Critically Ill Patients with Intravenous Ibuprofen
US 9,649,284 In forceTerm ends Aug 2, 2027 · Medium confidence
20-year base term ends Sep 30, 2029
Sep 30, 2009
Aug 2, 2027
May 16, 2017
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 30, 2009, when the earliest non-provisional application in its chain was filed (this one was filed Aug 13, 2015); a parent in its chain could not be resolved (the next row) | Sep 30, 2029 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,735,452, US 8,871,810, US 9,114,068, US 9,138,404, US 9,295,639, US 9,494,589) | capped to Aug 2, 2027 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 2, 2027 | Medium confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.